跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLYBORAL TABLET 5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
GLYBORAL TABLET 5 mg
Approved
THERAPEUTIC
GLYBORAL TABLET 5 mg
USV LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Jan 26, 2002
Approval ID
cdf12d876c5f2f79
Company
USV LIMITED
Type
Therapeutic
Approval Details
Approval Id
cdf12d876c5f2f79
Drug Name
GLYBORAL TABLET 5 mg
Product Name
GLYBORAL TABLET 5 mg
Approval Number
SIN11789P
Approval Date
2002-01-26
Registrant
ZYFAS MEDICAL CO
Licence Holder
ZYFAS MEDICAL CO
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A10BB01
Atc Item Name
glibenclamide
Pharma Manufacturer Name
ZYFAS MEDICAL CO
Company Detail Path
/organization/zyfas-medical-co
Active Ingredients
GLIBENCLAMIDE
5 mg
GLIBENCLAMIDE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 26, 2002
Approval ID
cdf12d876c5f2f79
Type
Therapeutic
Back to HSA Approvals